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Summary
. There was a 2% fall in overall renal transplant
numbers in 2014, with a signiﬁcant fall in kidney
donation from donors after circulatory death (10%).
. In 2014, death-censored renal transplant failure
rates in prevalent patients were similar to previous
years at 2.4% per annum. Transplant patient death
rates remained stable at 2.3 per 100 patient years.
. The median age of incident and prevalent renal
transplant patients in the UK was 50.6 and 53.3
years respectively.
. The median eGFR of prevalent renal transplant
recipients was 52.5 ml/min/1.73 m2.
. The median eGFR of patients one year after
transplantation was 57.4 ml/min/1.73 m2 post live
transplant, 53.6 ml/min/1.73 m2 post brainstem
death transplant and 50.1 ml/min/1.73 m2 post
circulatory death transplant.
. In 2014, 13% of prevalent transplant patients had
eGFR ,30 ml/min/1.73 m2.
. The median decline in eGFR slope beyond the
ﬁrst year after transplantation was −0.48 ml/min/
1.73 m2/year.
. In 2014, malignancy (26%) and infection (24%)
remained the commonest causes of death in patients
with a functioning renal transplant.
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Introduction
This chapter includes independent analyses regarding
renal transplant activity and survival data from the UK
Transplant Registry, held by the Organ Donation and
Transplantation Directorate (ODT) of NHS Blood and
Transplant (NHSBT). The UK Renal Registry (UKRR)
has performed additional analyses of renal transplant
recipient follow-up data examining demographics,
clinical and biochemical variables. NHSBT records all
the information regarding the episode of transplantation
(donor and recipient details) and the UKRR holds
additional information on key clinical and biochemical
variables in renal transplant recipients. The co-operation
between these two organisations results in a comprehen-
sive database describing the clinical care delivered to
renal transplant patients within the UK. This further
allows for the comparison of key outcomes between
centres and provides insight into the processes involved
in the care of such patients in the UK.
This chapter is divided into six sections: (1) transplant
activity, waiting list and survival data; (2) transplant
demographics; (3) clinical and laboratory outcomes; (4)
analysis of prevalent patients by chronic kidney disease
(CKD) stage; (5) eGFR slope analysis; and (6) cause of
death in transplant recipients. Methodology, results and
conclusions of these analyses are discussed in detail for
all six sections separately.
The UKRR methodology is described elsewhere [1].
The UKRR collects quarterly clinical data via an
electronic data extraction process from hospital based
renal IT systems on all patients receiving renal replace-
ment therapy. Throughout the chapter, the number
preceding the centre name in each ﬁgure indicates the
percentage of missing data for that centre for that
variable.
Unless otherwise speciﬁed, prevalent transplant
patients were deﬁned as patients with a functioning
renal transplant on the 31st December 2014.
A list of the recommended audit measures from the
Renal Association which are relevant to the transplant
population are given in appendix 1 of this chapter.
Several of the audit measures are not currently reported
by the UKRR in the annual report; the reasons behind
this are varied, but predominantly relate to a high pro-
portion of incomplete data or that the relevant variable
is not currently within the speciﬁed UKRR dataset.
Over time it is hoped to work with the renal community
to improve reporting across the range of recommended
standards.
Transplant activity, waiting list activity and survival
data
Introduction
NHSBT prospectively collects donor and recipient
data around the episode of transplantation. They also
request that transplant centres provide an annual paper
based data return on the status of the recipient’s graft
function. This enables ODT to generate comprehensive
analyses of renal transplant activity and graft survival
statistics.
NHSBT attributes a patient to the centre that per-
formed the transplant operation irrespective of where
the patient was cared for before or after the procedure
and hence only reports on transplant centre performance.
Methods
In 2014, there were 23 UK adult renal transplant centres, 19 in
England, two in Scotland and one each in Northern Ireland and
Wales.
Comprehensive information from 1999 onwards concerning
the number of patients on the transplant waiting list, the number
of transplants performed, the number of deceased kidney donors
(donor after brainstem death and donor after circulatory death),
living kidney donors, patient survival and graft survival is available
on the NHSBT website (http://www.organdonation.nhs.uk/ukt/
statistics/statistics.asp).
Results
During 2014, 3,200 kidney or kidney plus other organ
transplants were performed. The absolute number of
living kidney donors showed little change in 2014
representing 34.3% of all transplants performed whilst
donor after brainstem death transplants continued to
increase and comprised 37.7% of all kidney transplants
performed. A 10% fall in the number of transplants
from donors after circulatory death was also noted in
2014 (table 3.1).
There were small differences in one and ﬁve year risk-
adjusted patient and graft survival rates amongst UK
renal transplant centres (table 3.2). These graft survival
rates include grafts with primary non-function (which
are excluded from analysis by some countries).
Using data from the UKRR on prevalent renal trans-
plant patients on 1st January 2014, the death rate during
2014 was 2.3 per 100 patient years (CI 2.1–2.5) when cen-
sored for return to dialysis and 2.4 per 100 patient years
(CI 2.2–2.6) without censoring for dialysis. These death
rates are similar to those observed over the last few
years and have not shown any impact of the increasing
age of the transplanted cohort.
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Table 3.1. UK kidney and kidney plus other organ transplant numbers in the UK (including paediatric), 1/1/2012–31/12/2014
Organ 2012 2013 2014 % change 2013–2014
Donor after brainstem deatha 967 1,160 1,205 4
Donor after circulatory deathb 708 794 713 −10
Living donor kidney 1,034 1,104 1,097 −1
Kidney and liverc 17 11 12 9
Kidney and heart 3 1 1 0
Kidney and pancreasd 172 190 171 −10
Kidney and lung 0 0 1
Small bowel (inc kidney) 0 1 0
Total kidney transplants 2,901 3,261 3,200 −2
aIncludes en bloc kidney transplants (4 in 2012, 4 in 2013, 3 in 2014) and double kidney transplants (7 in 2012, 18 in 2013, 22 in 2014)
bIncludes en bloc kidney transplants (4 in 2012, 6 in 2013, 4 in 2014) and double kidney transplants (52 in 2012, 53 in 2013, 51 in 2014)
cIncludes DCD transplants (2 in 2013)
dIncludes DCD transplants (35 in 2012, 36 in 2013, 47 in 2014)
Table 3.2. Risk-adjusted ﬁrst adult kidney transplant only, graft and patient survival percentage rates for UK centres∗
Deceased donor Deceased donor Living kidney donor Living kidney donor
1 year survival 5 year survival 1 year survival 5 year survival
Centre Graft Patient Graft Patient Graft Patient Graft Patient
B QEH 91 97 81 89 96 100 89 95
Belfast 96 94 91 88 96 100 88 92
Bristol 92 94 86 86 98 99 95 95
Camb 93 96 86 92 99 99 94 98
Cardff 97 96 87 89 97 98 89 98
Covnt 87 90 92 90 93 99 86 95
Edin 92 94 83 87 96 98 86 93
Glasgw 95 97 88 89 97 97 92 96
L Barts 88 89 89 85 96 98 93 97
L Guys 93 97 82 90 96 98 93 95
L Rfree 94 96 90 94 98 99 96 97
L St.G 94 99 86 93 98 100 93 96
L West 94 98 88 91 96 99 84 94
Leeds 94 96 86 91 94 100 91 98
Leic 92 98 87 78 97 97 92 95
Liv Roy 92 94 83 90 95 100 90 95
M RI 95 96 88 88 99 98 94 95
Newc 93 96 82 87 100 99 90 97
Nottm 96 96 82 83 100 100 90 94
Oxford 93 96 91 88 95 97 97 95
Plymth 88 96 84 90 97 100 90 94
Ports 94 94 83 87 99 99 84 96
Sheff 94 94 85 95 97 100 94 98
All centres 93 96 86 89 97 99 91 95
Cohorts for survival rate estimation: 1 year survival: 1/4/2009 – 31/03/2013; 5 year survival: 1/4/2004 – 31/03/2009; ﬁrst grafts only –
re-grafts excluded for patient survival estimation. Since the cohorts to estimate 1- and 5-year survival are different, some centres may appear
to have 5 year survival better than 1 year survival
∗Information courtesy of NHSBT: number of transplants, patients and 95% CI for each estimate; statistical methodology for computing
risk-adjusted estimates can be obtained from the NHSBT website (see http://www.odt.nhs.uk/pdf/organ_speciﬁc_report_kidney_2014.pdf)
Outcomes in UK renal transplant
recipients in 2014
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During 2014, 2.4% of prevalent transplant patients
experienced graft failure (excluding death as a cause of
graft failure) maintaining the fall in graft failure rates
noted over the last couple of years. Whilst it might be
premature to assume that graft failure rates are falling
in the UK the 0.5% fall noted in the last ﬁve years is
certainly encouraging.
Conclusions
In 2014, there was a 2% fall in overall renal transplant
numbers, with a signiﬁcant fall in kidney donation
from donors after circulatory death (10%). The graft
failure rate of 2.4% per annum and patient death rate
of 2.3 per 100 patient years were similar to those noted
in 2013.
Transplant demographics
Introduction
Since 2008, all UK renal centres have established
electronic linkage to the UKRR or Scottish Renal Regis-
try, giving the UKRR complete coverage of individual
patient level data across the UK.
The following sections need to be interpreted in the
context of variable repatriation policies; some transplant
centres continue to follow up and report on all patients
they transplant, whereas others refer patients back to
non-transplant centres for most or all ongoing post-
transplant care. Some transplant centres only refer back
patients when their graft is failing. The time post-
transplantation that a patient is referred back to their
local centre varies between transplant centres. The
UKRR is able to detect duplicate patients (being reported
from both transplant and referring centres) and in such
situations care is usually attributed to the referring centre
(see appendix B2 for allocation procedure). This process
may result in some discrepancies in transplant numbers
particularly in Oxford/Reading and Clywd/Liverpool
Royal.
Methods
As Colchester did not have any transplant patients they were
excluded from some of the analyses, though their dialysis patients
were included in the relevant dialysis population denominators.
For the analysis of primary renal diagnosis (PRD) in transplant
recipients, a few centres were excluded from some of the take-on
years because of concerns relating to the reliability of PRD coding
(with these centres submitting a high percentage of uncertain or
missing aetiology codes).
Information on patient demographics (age, gender, ethnicity
and PRD) for patients in a given renal centre was obtained from
UKRR patient registration data ﬁelds. Individual patients were
assigned to the centre that returned data for them during 2014.
The prevalence of transplant patients in areas covered by individ-
ual Clinical Commissioning Groups (CCG) or Health Board/
Social Care Areas (HB) was estimated based on the postcode of
the registered address for patients on renal replacement therapy
(RRT). Data on ethnic origin, supplied as Patient Administration
System (PAS) codes, were retrieved from ﬁelds within renal centre
IT systems. For the purpose of this analysis, patients were grouped
into Whites, South Asians, Blacks, Others and Unknown. The
details of ethnicity regrouping into the above categories are
provided in appendix H: Coding https://www.renalreg.org/
publications-reports/.
Results and Conclusions
Prevalent transplant numbers across the UK are
described in table 3.3.
The prevalence of renal transplant recipients in each
CCG/HB in England, Northern Ireland (Health and Social
Care Trust Areas), Scotland (Health Boards) and Wales
(Local Health Boards) and the proportion of prevalent
patients according to modality in the renal centres across
the UK is described in tables 3.4 and 3.5 respectively.
After standardisation for age and gender, unexplained
variability was evident in the prevalence of renal transplant
recipients, with some areas having higher than the pre-
dicted number of prevalent transplant patients per million
population and others lower. There are a number of
potential explanations for these inconsistencies, including
Table 3.3. The prevalence per million population (pmp) of renal transplants in adults in the UK on 31/12/2014, by country
England N Ireland Scotland Wales UK
Number of prevalent transplant patients 26,108 912 2,610 1,534 31,164
Total population, mid-2014 estimates from ONS∗ (millions) 54.3 1.8 5.3 3.1 64.6
Prevalence pmp transplant 481 496 488 496 482
∗Ofﬁce of National Statistics, UK
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Table 3.4 Prevalence per million population of patients with a renal transplant and age/gender standardised rate ratio in the UK, as
on 31st December 2010–2014, by CCG/HB
CCG/HB – CCG in England, Health and Social Care Areas in Northern Ireland, Local Health Boards in Wales and Health Boards in Scotland
O/E – age and gender standardised transplant prevalence rate ratio
LCL – lower 95% conﬁdence limit
UCL – upper 95% conﬁdence limit
pmp – per million population
CCG/HBs with signiﬁcantly high average rate ratios are bold in greyed areas
CCG/HBs with signiﬁcantly low average rate ratios are italicised in greyed areas
Mid-2013 population data from the Ofﬁce for National Statistics, National Records of Scotland and the Northern Ireland Statistics and
Research Agency – based on the 2011 census
% non-White – percentage of the CCG/HB population that is non-White, from 2011 Census
Crude rate pmp
Age and gender
standardised rate ratio 2014
%
UK area CCG/HB
Total
population 2010 2011 2012 2013 2014 O/E 95% LCL 95% UCL
non-
White
Cheshire,
Warrington
and Wirral
NHS Eastern Cheshire 195,500 358 389 414 445 465 0.88 0.72 1.08 3.7
NHS South Cheshire 177,200 389 389 401 446 502 0.98 0.80 1.21 2.9
NHS Vale Royal 102,000 274 284 314 363 372 0.72 0.53 0.99 2.1
NHS Warrington 205,100 361 380 405 463 483 0.96 0.79 1.17 4.1
NHS West Cheshire 229,000 384 406 428 463 493 0.97 0.80 1.16 2.8
NHS Wirral 320,300 343 350 347 362 368 0.73 0.61 0.88 3.0
Durham,
Darlington
and Tees
NHS Darlington 105,400 332 389 398 446 493 0.99 0.76 1.30 3.8
NHS Durham Dales, Easington and Sedgeﬁeld 272,900 410 451 462 506 550 1.06 0.90 1.25 1.2
NHS Hartlepool and Stockton-on-Tees 285,900 430 413 437 469 497 1.01 0.86 1.19 4.4
NHS North Durham 243,100 399 395 411 424 432 0.86 0.71 1.04 2.5
NHS South Tees 273,900 526 566 577 577 595 1.23 1.05 1.43 6.7
Greater
Manchester
NHS Bolton 280,100 453 500 532 546 575 1.21 1.03 1.41 18.1
NHS Bury 186,500 391 407 440 445 493 1.01 0.82 1.23 10.8
NHS Central Manchester 182,200 329 351 368 428 466 1.26 1.02 1.56 48.0
NHS Heywood, Middleton & Rochdale 212,100 401 438 462 490 467 0.98 0.81 1.20 18.3
NHS North Manchester 170,700 270 305 340 375 404 0.98 0.78 1.25 30.8
NHS Oldham 227,300 383 400 409 466 462 1.00 0.83 1.21 22.5
NHS Salford 239,000 339 360 410 414 443 0.97 0.80 1.17 9.9
NHS South Manchester 161,500 235 279 316 340 378 0.89 0.69 1.14 19.6
NHS Stockport 285,000 403 414 432 460 467 0.93 0.78 1.10 7.9
NHS Tameside and Glossop 253,700 410 449 457 477 512 1.03 0.87 1.22 8.2
NHS Trafford 230,200 326 348 378 404 456 0.94 0.78 1.14 14.5
NHS Wigan Borough 319,700 394 460 491 544 557 1.10 0.95 1.27 2.7
Lancashire NHS Blackburn with Darwen 147,400 332 380 407 455 495 1.09 0.87 1.37 30.8
NHS Blackpool 141,400 347 347 403 481 523 1.04 0.83 1.30 3.3
NHS Chorley and South Ribble 169,500 354 407 407 448 472 0.93 0.74 1.15 2.9
NHS East Lancashire 372,300 408 440 446 475 491 0.99 0.86 1.15 11.9
NHS Fylde & Wyre 165,800 332 344 386 416 422 0.79 0.63 1.00 2.1
NHS Greater Preston 201,700 317 327 372 392 421 0.88 0.72 1.09 14.7
NHS Lancashire North 159,500 326 332 332 345 364 0.75 0.58 0.97 4.0
NHS West Lancashire 111,300 341 359 386 386 395 0.78 0.58 1.05 1.9
Merseyside NHS Halton 126,000 389 413 452 460 500 1.01 0.79 1.29 2.2
NHS Knowsley 146,100 383 376 397 418 424 0.88 0.68 1.12 2.8
NHS Liverpool 470,800 346 374 391 416 444 0.96 0.84 1.10 11.1
NHS South Sefton 158,900 359 378 422 453 459 0.90 0.72 1.14 2.2
NHS Southport and Formby 114,300 306 315 289 350 359 0.69 0.51 0.94 3.1
NHS St Helens 176,200 335 358 363 409 465 0.91 0.74 1.14 2.0
Outcomes in UK renal transplant
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Table 3.4 Continued
Crude rate pmp
Age and gender
standardised rate ratio 2014
%
UK area CCG/HB
Total
population 2010 2011 2012 2013 2014 O/E 95% LCL 95% UCL
non-
White
Cumbria,
Northumber-
land, Tyne
and Wear
NHS Cumbria 504,100 391 399 423 450 472 0.89 0.78 1.01 1.5
NHS Gateshead 200,000 385 420 440 435 440 0.88 0.71 1.08 3.7
NHS Newcastle North and East 143,900 424 466 438 452 486 1.14 0.90 1.44 10.7
NHS Newcastle West 142,900 308 322 336 357 364 0.81 0.62 1.06 18.3
NHS North Tyneside 202,200 564 579 579 579 549 1.08 0.90 1.30 3.4
NHS Northumberland 315,800 383 427 437 475 494 0.92 0.79 1.08 1.6
NHS South Tyneside 148,500 471 505 512 559 518 1.02 0.82 1.28 4.1
NHS Sunderland 276,100 431 467 493 514 522 1.04 0.88 1.22 4.1
North
Yorkshire
and Humber
NHS East Riding of Yorkshire 314,600 388 404 426 490 493 0.92 0.78 1.07 1.9
NHS Hambleton, Richmondshire and Whitby 153,600 286 319 332 371 449 0.85 0.67 1.08 2.7
NHS Harrogate and Rural District 158,200 461 468 524 531 562 1.09 0.88 1.34 3.7
NHS Hull 257,600 373 392 419 458 478 1.03 0.87 1.23 5.9
NHS North East Lincolnshire 159,800 369 419 444 463 457 0.93 0.74 1.17 2.6
NHS North Lincolnshire 168,800 273 290 290 314 356 0.70 0.54 0.90 4.0
NHS Scarborough and Ryedale 110,100 436 463 445 427 463 0.88 0.67 1.16 2.5
NHS Vale of York 349,100 401 427 481 516 544 1.10 0.95 1.26 4.0
South
Yorkshire
and
Bassetlaw
NHS Barnsley 235,800 399 403 411 433 475 0.94 0.78 1.13 2.1
NHS Bassetlaw 113,700 308 308 317 326 387 0.74 0.55 0.99 2.6
NHS Doncaster 303,600 343 379 402 405 448 0.90 0.76 1.07 4.7
NHS Rotherham 258,700 394 429 452 487 541 1.08 0.91 1.27 6.4
NHS Shefﬁeld 560,100 355 380 393 416 429 0.95 0.83 1.07 16.3
West
Yorkshire
NHS Airedale, Wharfedale and Craven 158,500 454 435 448 473 492 0.97 0.78 1.22 11.1
NHS Bradford City 82,700 387 399 483 544 556 1.58 1.18 2.11 72.2
NHS Bradford Districts 334,600 457 469 520 562 583 1.29 1.12 1.49 28.7
NHS Calderdale 206,400 470 504 538 533 514 1.03 0.85 1.24 10.3
NHS Greater Huddersﬁeld 240,400 399 433 462 474 507 1.04 0.87 1.24 17.4
NHS Leeds North 199,900 380 420 435 445 490 1.00 0.82 1.22 17.4
NHS Leeds South and East 241,000 382 402 419 465 469 1.05 0.87 1.26 18.3
NHS Leeds West 320,500 318 340 390 427 468 1.07 0.91 1.25 10.8
NHS North Kirklees 187,900 474 495 500 580 649 1.39 1.17 1.66 25.3
NHS Wakeﬁeld 329,700 334 349 370 388 403 0.80 0.67 0.94 4.6
Arden,
Herefordshire
and
Worcester-
shire
NHS Coventry and Rugby 431,200 387 410 431 448 499 1.11 0.97 1.26 22.2
NHS Herefordshire 186,100 285 301 333 339 365 0.70 0.55 0.88 1.8
NHS Redditch and Bromsgrove 179,300 351 357 390 402 435 0.86 0.69 1.07 6.0
NHS South Warwickshire 259,200 405 409 463 482 494 0.97 0.81 1.15 7.0
NHS South Worcestershire 294,500 323 336 346 374 391 0.76 0.63 0.91 3.7
NHS Warwickshire North 188,100 409 452 447 457 457 0.90 0.73 1.11 6.5
NHS Wyre Forest 98,400 356 356 376 406 386 0.73 0.53 1.01 2.8
Birmingham
and the
Black
Country
NHS Birmingham CrossCity 725,400 358 378 403 425 458 1.07 0.96 1.19 35.2
NHS Birmingham South and Central 201,200 368 358 353 418 482 1.17 0.96 1.43 40.4
NHS Dudley 314,400 299 302 283 318 337 0.68 0.56 0.82 10.0
NHS Sandwell and West Birmingham 480,100 354 362 385 444 452 1.05 0.92 1.20 45.3
NHS Solihull 208,900 297 316 335 345 373 0.75 0.60 0.93 10.9
NHS Walsall 272,200 378 408 430 474 511 1.09 0.92 1.28 21.1
NHS Wolverhampton 251,600 302 294 314 382 409 0.88 0.73 1.07 32.0
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Table 3.4 Continued
Crude rate pmp
Age and gender
standardised rate ratio 2014
%
UK area CCG/HB
Total
population 2010 2011 2012 2013 2014 O/E 95% LCL 95% UCL
non-
White
Derbyshire
and
Nottingham-
shire
NHS Erewash 94,900 284 284 295 400 432 0.86 0.64 1.17 3.2
NHS Hardwick 109,300 284 275 275 265 320 0.62 0.44 0.86 1.8
NHS Mansﬁeld & Ashﬁeld 193,900 356 402 454 474 505 1.00 0.82 1.22 2.5
NHS Newark & Sherwood 117,000 453 462 513 564 607 1.17 0.93 1.48 2.4
NHS North Derbyshire 272,200 331 356 401 401 408 0.77 0.64 0.92 2.5
NHS Nottingham City 310,800 306 322 344 380 396 0.96 0.80 1.15 28.5
NHS Nottingham North & East 147,600 345 386 413 440 400 0.79 0.61 1.01 6.2
NHS Nottingham West 111,200 458 476 485 548 584 1.14 0.90 1.46 7.3
NHS Rushcliffe 112,800 328 372 390 443 417 0.82 0.61 1.08 6.9
NHS Southern Derbyshire 518,200 355 390 413 442 463 0.95 0.83 1.07 11.0
East Anglia NHS Cambridgeshire and Peterborough 855,000 371 396 408 433 457 0.95 0.86 1.04 9.5
NHS Great Yarmouth & Waveney 213,800 299 313 337 430 477 0.93 0.77 1.13 2.7
NHS Ipswich and East Suffolk 396,100 336 369 371 429 444 0.88 0.76 1.01 5.6
NHS North Norfolk 168,500 368 404 374 499 481 0.88 0.71 1.09 1.5
NHS Norwich 195,000 277 303 297 390 410 0.88 0.71 1.10 7.3
NHS South Norfolk 237,400 383 362 383 476 489 0.95 0.79 1.14 2.6
NHS West Norfolk 171,500 332 338 379 397 432 0.83 0.66 1.04 2.6
NHS West Suffolk 223,800 362 371 407 411 416 0.84 0.68 1.02 4.6
Essex NHS Basildon and Brentwood 252,800 364 384 388 475 475 0.98 0.82 1.17 7.1
NHS Castle Point, Rayleigh and Rochford 172,500 359 359 371 417 493 0.94 0.76 1.16 3.0
NHS Mid Essex 381,500 388 427 417 472 480 0.94 0.82 1.09 4.4
NHS North East Essex 316,300 345 379 395 433 490 0.99 0.84 1.15 5.5
NHS Southend 175,800 341 358 404 461 495 1.02 0.82 1.25 8.4
NHS Thurrock 160,800 323 361 373 379 404 0.87 0.68 1.11 14.1
NHS West Essex 293,200 361 368 406 419 454 0.92 0.77 1.09 8.2
Hertfordshire
and the
South
Midlands
NHS Bedfordshire 425,900 404 413 470 488 528 1.07 0.94 1.21 11.2
NHS Corby 64,200 327 358 327 327 343 0.72 0.48 1.10 4.5
NHS East and North Hertfordshire 546,300 357 372 403 428 458 0.95 0.84 1.08 10.4
NHS Herts Valleys 575,800 384 406 419 448 485 1.01 0.90 1.13 14.6
NHS Luton 208,000 380 433 471 524 596 1.40 1.17 1.67 45.3
NHS Milton Keynes 261,400 375 413 444 448 509 1.09 0.92 1.29 19.6
NHS Nene 626,600 393 409 402 429 474 0.96 0.86 1.07 9.1
Leicestershire
and
Lincolnshire
NHS East Leicestershire and Rutland 321,900 373 391 410 432 481 0.94 0.80 1.10 9.8
NHS Leicester City 333,800 503 536 560 617 677 1.60 1.41 1.83 49.5
NHS Lincolnshire East 229,400 366 370 392 423 445 0.83 0.68 1.00 2.0
NHS Lincolnshire West 229,600 327 344 357 396 422 0.85 0.70 1.04 3.0
NHS South Lincolnshire 142,600 281 281 309 309 365 0.70 0.53 0.92 2.3
NHS South West Lincolnshire 122,800 252 309 334 358 374 0.72 0.54 0.96 2.3
NHS West Leicestershire 377,300 419 445 461 482 501 1.00 0.86 1.15 6.9
Shropshire
and
Staffordshire
NHS Cannock Chase 133,600 337 329 329 359 367 0.72 0.54 0.95 2.4
NHS East Staffordshire 124,600 233 257 249 329 329 0.66 0.48 0.89 9.0
NHS North Staffordshire 214,400 354 382 410 443 443 0.86 0.70 1.05 3.5
NHS Shropshire 308,600 347 360 344 356 369 0.70 0.59 0.84 2.0
NHS South East Staffs and Seisdon and
Peninsular
224,500 401 392 379 423 450 0.86 0.71 1.05 3.6
NHS Stafford and Surrounds 151,700 316 343 363 402 435 0.83 0.65 1.05 4.7
NHS Stoke on Trent 258,400 410 406 433 433 460 0.96 0.81 1.15 11.0
NHS Telford & Wrekin 168,500 285 291 285 332 332 0.69 0.53 0.89 7.3
Outcomes in UK renal transplant
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Table 3.4 Continued
Crude rate pmp
Age and gender
standardised rate ratio 2014
%
UK area CCG/HB
Total
population 2010 2011 2012 2013 2014 O/E 95% LCL 95% UCL
non-
White
London NHS Barking & Dagenham 194,400 329 391 386 453 484 1.20 0.98 1.47 41.7
NHS Barnet 369,100 463 515 580 607 615 1.37 1.20 1.56 35.9
NHS Camden 229,700 392 440 466 470 474 1.07 0.89 1.30 33.7
NHS City and Hackney 265,000 328 328 343 392 441 1.07 0.89 1.28 44.6
NHS Enﬁeld 320,500 484 543 596 618 671 1.51 1.33 1.73 39.0
NHS Haringey 263,400 421 459 501 528 581 1.32 1.13 1.55 39.5
NHS Havering 242,100 310 326 339 392 384 0.80 0.65 0.98 12.3
NHS Islington 215,700 459 496 538 566 603 1.39 1.17 1.65 31.8
NHS Newham 318,200 305 317 368 431 497 1.26 1.08 1.47 71.0
NHS Redbridge 288,300 413 437 496 524 590 1.35 1.16 1.57 57.5
NHS Tower Hamlets 272,900 264 268 304 326 381 1.00 0.82 1.21 54.8
NHS Waltham Forest 265,800 406 433 433 470 542 1.25 1.06 1.47 47.8
NHS Brent 317,300 574 589 640 712 744 1.67 1.47 1.90 63.7
NHS Central London (Westminster) 162,700 449 455 473 498 559 1.17 0.95 1.43 36.2
NHS Ealing 342,500 569 593 625 642 707 1.57 1.39 1.78 51.0
NHS Hammersmith and Fulham 178,700 431 420 437 470 492 1.11 0.90 1.37 31.9
NHS Harrow 243,400 703 703 723 731 801 1.73 1.50 1.99 57.8
NHS Hillingdon 286,800 502 554 586 593 655 1.47 1.27 1.69 39.4
NHS Hounslow 262,400 492 507 522 591 644 1.44 1.24 1.67 48.6
NHS West London (Kensington and Chelsea,
Queen’s Park and Paddington)
219,800 469 464 460 482 519 1.09 0.90 1.31 33.4
NHS Bexley 236,700 499 511 524 566 579 1.23 1.04 1.46 18.1
NHS Bromley 317,900 475 475 503 525 547 1.13 0.97 1.31 15.7
NHS Croydon 372,800 338 365 378 416 443 0.97 0.83 1.13 44.9
NHS Greenwich 264,000 348 383 420 458 542 1.25 1.06 1.47 37.5
NHS Kingston 166,800 390 402 438 456 492 1.08 0.87 1.34 25.5
NHS Lambeth 314,200 309 350 395 442 484 1.12 0.96 1.32 42.9
NHS Lewisham 286,200 370 381 391 468 510 1.16 0.99 1.37 46.5
NHS Merton 203,200 403 433 472 536 566 1.24 1.03 1.49 35.1
NHS Richmond 191,400 308 334 361 392 418 0.86 0.69 1.07 14.0
NHS Southwark 298,500 469 499 546 593 637 1.47 1.28 1.70 45.8
NHS Sutton 195,900 434 449 485 495 500 1.05 0.86 1.28 21.4
NHS Wandsworth 310,500 328 364 386 415 454 1.05 0.89 1.24 28.6
Bath,
Gloucester-
shire, Swindon
and Wiltshire
NHS Bath and North East Somerset 180,100 283 283 289 361 400 0.84 0.67 1.06 5.4
NHS Gloucestershire 605,700 352 383 378 421 424 0.83 0.74 0.94 4.6
NHS Swindon 219,300 410 438 447 483 520 1.07 0.89 1.29 10.0
NHS Wiltshire 479,600 352 379 398 402 434 0.86 0.75 0.98 3.4
Bristol, North
Somerset,
Somerset and
South Glou-
cestershire
NHS Bristol 437,500 464 471 494 530 549 1.26 1.11 1.42 16.0
NHS North Somerset 206,100 461 471 505 534 534 1.04 0.86 1.25 2.7
NHS Somerset 538,100 379 411 414 435 452 0.87 0.77 0.99 2.0
NHS South Gloucestershire 269,100 453 468 476 502 502 1.01 0.86 1.20 5.0
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Table 3.4 Continued
Crude rate pmp
Age and gender
standardised rate ratio 2014
%
UK area CCG/HB
Total
population 2010 2011 2012 2013 2014 O/E 95% LCL 95% UCL
non-
White
Devon,
Cornwall and
Isles of Scilly
NHS Kernow 543,600 456 482 521 548 570 1.09 0.97 1.22 1.8
NHS North, East, West Devon 874,300 424 431 455 491 503 1.00 0.91 1.10 3.0
NHS South Devon and Torbay 275,000 469 487 495 553 596 1.12 0.97 1.31 2.1
Kent and
Medway
NHS Ashford 121,700 460 485 534 534 575 1.18 0.93 1.49 6.3
NHS Canterbury and Coastal 202,400 400 425 494 504 553 1.16 0.97 1.40 5.9
NHS Dartford, Gravesham and Swanley 251,900 476 465 484 512 548 1.14 0.96 1.34 13.0
NHS Medway 271,100 406 409 432 468 480 1.01 0.85 1.20 10.4
NHS South Kent Coast 203,600 344 368 388 417 467 0.91 0.74 1.11 4.5
NHS Swale 109,600 420 520 547 611 620 1.26 1.00 1.60 3.8
NHS Thanet 136,800 409 461 541 592 629 1.27 1.03 1.57 4.5
NHS West Kent 467,500 347 361 385 409 430 0.87 0.75 0.99 4.9
Surrey and
Sussex
NHS Brighton & Hove 278,100 349 356 363 370 388 0.84 0.70 1.02 10.9
NHS Coastal West Sussex 480,200 394 423 421 456 479 0.93 0.82 1.06 3.8
NHS Crawley 109,000 257 284 294 294 321 0.70 0.50 0.98 20.1
NHS East Surrey 177,900 326 337 343 377 365 0.74 0.58 0.94 8.3
NHS Eastbourne, Hailsham and Seaford 183,500 316 327 338 360 371 0.73 0.58 0.93 4.4
NHS Guildford and Waverley 207,800 284 270 308 322 337 0.70 0.55 0.88 7.2
NHS Hastings & Rother 181,800 325 352 347 369 396 0.77 0.61 0.97 4.6
NHS High Weald Lewes Havens 169,100 331 337 396 402 426 0.81 0.64 1.02 3.1
NHS Horsham and Mid Sussex 225,300 324 324 328 355 408 0.81 0.66 0.99 4.9
NHS North West Surrey 340,200 420 429 453 476 494 1.00 0.86 1.17 12.5
NHS Surrey Downs 284,700 393 397 400 432 453 0.90 0.75 1.07 9.1
NHS Surrey Heath 94,400 477 508 540 508 466 0.92 0.68 1.24 9.3
Thames
Valley
NHS Aylesbury Vale 199,500 491 521 541 562 577 1.15 0.96 1.38 9.7
NHS Bracknell and Ascot 134,400 417 454 476 499 499 1.03 0.81 1.31 9.5
NHS Chiltern 319,400 426 423 470 498 498 1.01 0.86 1.18 15.8
NHS Newbury and District 105,700 501 568 568 577 568 1.13 0.88 1.46 4.4
NHS North & West Reading 99,900 410 410 440 500 490 0.98 0.74 1.30 10.4
NHS Oxfordshire 652,300 423 437 469 483 520 1.09 0.98 1.21 9.3
NHS Slough 143,000 601 608 636 762 811 1.91 1.60 2.30 54.3
NHS South Reading 109,000 495 504 495 532 587 1.42 1.11 1.82 30.5
NHS Windsor, Ascot and Maidenhead 139,900 408 436 508 558 593 1.23 0.99 1.53 14.7
NHS Wokingham 157,900 405 418 443 450 481 0.96 0.77 1.21 11.6
Wessex NHS Dorset 754,500 404 412 410 419 441 0.87 0.78 0.96 4.0
NHS Fareham and Gosport 197,100 396 411 406 467 487 0.96 0.79 1.17 3.4
NHS Isle of Wight 138,400 354 361 376 354 354 0.67 0.50 0.88 2.7
NHS North East Hampshire and Farnham 207,500 366 366 385 414 453 0.93 0.76 1.14 9.7
NHS North Hampshire 217,800 331 358 372 386 404 0.81 0.66 0.99 6.4
NHS Portsmouth 207,500 371 371 386 410 410 0.92 0.75 1.14 11.6
NHS South Eastern Hampshire 209,900 414 405 434 448 510 1.00 0.82 1.20 3.1
NHS Southampton 242,100 326 372 405 446 483 1.12 0.93 1.34 14.1
NHS West Hampshire 548,000 398 411 422 438 445 0.87 0.77 0.98 3.9
Wales Betsi Cadwaladr University 692,000 361 361 355 341 358 0.70 0.62 0.80 2.5
Powys Teaching 132,700 414 407 354 377 384 0.72 0.54 0.94 1.6
Hywel Dda 383,900 401 430 425 487 492 0.96 0.83 1.11 2.2
Abertawe Bro Morgannwg University 520,700 490 545 574 601 613 1.23 1.11 1.38 3.9
Cwm Taf 295,100 630 664 688 742 732 1.49 1.30 1.70 2.6
Aneurin Bevan 579,100 499 521 582 597 604 1.21 1.09 1.35 3.9
Cardiff and Vale University 478,900 441 466 497 510 505 1.11 0.98 1.26 12.2
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Table 3.4 Continued
Crude rate pmp
Age and gender
standardised rate ratio 2014
%
UK area CCG/HB
Total
population 2010 2011 2012 2013 2014 O/E 95% LCL 95% UCL
non-
White
Scotland Ayrshire and Arran 372,200 395 387 414 435 465 0.89 0.76 1.03 1.2
Borders 113,900 465 465 527 544 553 1.02 0.79 1.30 1.3
Dumfries and Galloway 150,300 366 399 393 393 439 0.81 0.64 1.03 1.2
Fife 366,900 333 360 376 409 422 0.83 0.71 0.97 2.4
Forth Valley 299,700 317 344 370 397 444 0.87 0.73 1.03 2.2
Grampian 579,200 373 387 406 439 447 0.89 0.79 1.01 4.0
Greater Glasgow and Clyde 1,137,900 424 439 485 522 549 1.12 1.04 1.21 7.3
Highland 321,000 483 480 483 505 530 0.99 0.85 1.15 1.3
Lanarkshire 652,600 408 428 461 481 527 1.04 0.93 1.15 2.0
Lothian 849,700 347 364 374 385 410 0.84 0.76 0.94 5.6
Orkney 21,600 371 371 371 371 278 0.51 0.23 1.14 0.7
Shetland 23,200 259 216 259 259 259 0.50 0.22 1.11 1.5
Tayside 412,200 405 417 425 446 459 0.91 0.79 1.05 3.2
Western Isles 27,400 255 292 292 292 292 0.54 0.27 1.07 0.9
Northern
Ireland
Belfast 349,600 383 395 429 458 509 1.12 0.97 1.29 3.2
Northern 466,700 358 373 384 414 456 0.95 0.83 1.09 1.2
Southern 365,700 306 345 388 418 468 1.02 0.88 1.19 1.2
South Eastern 350,800 359 388 393 419 465 0.95 0.82 1.11 1.3
Western 296,900 347 354 360 438 522 1.12 0.95 1.31 1.0
Table 3.5. Distribution of prevalent patients on RRT by centre and modality on 31/12/2014
Centre N % HD % PD % transplant
Transplant centres
B QEH 2,137 45 7 49
Belfast 750 27 2 71
Bristol 1,460 36 5 59
Camb 1,243 30 2 68
Cardff 1,593 31 5 64
Covnt 962 41 9 50
Edinb 758 37 3 60
Glasgw 1,641 36 3 61
L Barts 2,236 43 10 47
L Guys 1,924 34 2 64
L Rfree 2,010 35 7 57
L St.G 797 37 6 55
L West 3,244 44 2 54
Leeds 1,500 35 4 61
Leic 2,151 42 6 52
Liv Roy 1,312 28 5 67
M RI 1,815 29 4 67
Newc 983 29 5 66
Nottm 1,066 34 8 58
Oxford 1,658 28 5 67
Plymth 510 27 7 66
Ports 1,595 39 5 56
Sheff 1,360 43 5 53
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Table 3.5. Continued
Centre N % HD % PD % transplant
Dialysis centres
Abrdn 515 41 5 53
Airdrie 399 46 2 51
Antrim 229 54 6 41
B Heart 638 65 5 30
Bangor∗ 99 84 16
Basldn 280 62 10 28
Bradfd 549 41 4 56
Brightn 916 47 7 46
Carlis 250 30 11 59
Carsh 1,565 51 9 41
Chelms 263 51 10 38
Clwyd 165 55 7 38
Colchr 119 100
D & Gall 133 37 13 50
Derby 519 46 17 37
Donc 285 64 9 26
Dorset 665 42 8 51
Dudley 305 58 18 25
Dundee 414 43 6 51
Exeter 950 44 10 46
Glouc 429 49 10 41
Hull 804 41 10 49
Inverns 227 31 7 62
Ipswi 369 34 8 57
Kent 1,019 40 6 53
Klmarnk 306 46 12 42
Krkcldy 283 52 6 42
L Kings 1,025 53 9 38
Liv Ain 218 74 19 7
Middlbr 858 39 2 59
Newry 208 44 8 48
Norwch 691 47 5 48
Prestn 1,171 48 5 47
Redng 763 39 10 52
Salford 969 42 9 49
Shrew 349 55 9 36
Stevng 782 62 3 34
Sthend 238 49 8 43
Stoke 776 43 11 46
Sund 452 47 4 49
Swanse 704 47 8 45
Truro 380 39 6 55
Ulster 149 66 3 31
West NI 272 43 5 52
Wirral 246 83 9 7
Wolve 575 55 14 32
Wrexm 281 40 11 49
York 461 31 6 63
England 49,842 41 6 52
N Ireland 1,608 39 4 57
Scotland 4,676 40 5 56
Wales 2,842 39 7 54
UK 58,968 41 6 53
∗Bangor was only able to report on a few transplant patients with the rest reported by Liverpool Royal. These have thus been reallocated to
Liverpool Royal to maintain consistency with previous annual reports, for analyses shown in tables 3.3 and 3.5 only
Blank cells: no patients on that modality
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geographical differences in access to renal transplantation
in the UK. This has previously been analysed in detail by
the UKRR [2] and is currently the focus of a large national
study (access to Transplant and Transplant Outcome
Measures (ATTOM)).
The proportion of prevalent RRT patients with a trans-
plant relative to the number on dialysis has gradually
risen over the last decade.
Age and gender
The gender ratio amongst incident and prevalent
transplant patients has remained stable for at least the
last ten years (table 3.6, ﬁgure 3.1). Note, absolute patient
numbers differ from those published in previous reports
as a result of additional data validation and reallocation
of patients. The average age of incident transplant
patients has steadily increased during the same time
period. There has also been a gradual increase in the
average age of prevalent transplant patients, which
could reﬂect the increasing age at which patients are
transplanted and/or improved survival after renal
transplantation over the last few years. The prevalent
transplant patient workload across the UK increased to
31,164 patients at the end of 2014. The continued expan-
sion of this patient group means there is a need for careful
planning by renal centres for future service provision and
resource allocation.
Primary renal diagnosis
The primary renal diagnosis of patients receiving
kidney transplants in the UK has remained relatively
stable over the last ﬁve years (table 3.7).
Ethnicity
It was difﬁcult to compare the proportion of patients
within each ethnic group receiving a transplant to those
commencing dialysis from the same group because data
on ethnicity were missing in a considerable number of
patients who were classiﬁed as ethnicity ‘unknown’
(table 3.8). The percentages of patients with unknown
ethnicity between 2009 and 2013 provided in this year’s
chapter are different from those in last year’s chapter
[3]; this reﬂects retrospective input of ethnicity data,
improving data completeness.
Table 3.6. Median age and gender ratio of incident and prevalent transplant patients 2009–2014
Incident transplants Prevalent transplants∗
Year N Median age M:F ratio N Median age M:F ratio
2009 2,488 48.3 1.6 23,500 50.8 1.5
2010 2,584 49.6 1.7 24,889 51.2 1.6
2011 2,627 49.1 1.7 26,180 51.7 1.6
2012 2,781 50.4 1.6 27,541 52.3 1.6
2013 3,123 50.3 1.6 29,467 52.8 1.6
2014 3,020 50.6 1.5 31,164 53.3 1.5
∗As on 31st December for given year
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million population by age and gender on
31/12/2014
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Clinical and laboratory outcomes
Introduction
There continued to be marked variation in the com-
pleteness of data (tables 3.9a, 3.9b) reported by each
renal centre, particularly for blood pressure. Better data
records (or possibly better extraction of data held within
renal IT systems) would facilitate more meaningful
comparisons between centres and help to determine the
causes of inter-centre differences in outcomes. For this
reason, along with differences in repatriation policies of
prevalent transplant patients between centres as high-
lighted previously, caution needs to be exercised when
comparing centre performance.
The 71 renal centres in the UK comprise 52 centres
in England, ﬁve in Wales, ﬁve in Northern Ireland and
nine in Scotland. Colchester was reported as having no
transplanted patients and was therefore excluded. After
exclusion of this centre, prevalent patient data from 70
renal centres across the UK were analysed.
For the one year post-transplant analyses, in which
patients were assigned to the centre that performed
their transplant, all 23 transplant centres across the UK
were included in the analysis.
Methods
Data for key laboratory variables are reported for all prevalent
patients with valid data returns for a given renal centre (both
transplanting and non-transplanting centres) and for one year
post-transplant results for patients transplanted 2007–2013, with
patients attributed to the transplant centre that performed the
procedure.
Time since transplantation may have a signiﬁcant effect on key
biochemical and clinical variables and this is likely to be indepen-
dent of a centre’s clinical practices. Therefore, inter-centre
comparison of data on prevalent transplant patients is open to
bias. To minimise bias relating to ﬂuctuations in biochemical
and clinical parameters occurring in the initial post-transplant
period, one year post-transplantation outcomes are also reported.
It is presumed that patient selection policies and local clinical
practices are more likely to be relevant in inﬂuencing outcomes
12 months post-transplant and therefore comparison of outcomes
between centres is more robust. However, even the 12 months
post-transplant comparisons could be biased by the fact that in
some centres, repatriation of patients only occurs if the graft is fail-
ing whereas in others it only occurs if the graft function is stable.
Centres with ,20 patients or ,50% data completeness have
been excluded from the ﬁgures. Scottish centres were also excluded
from blood pressure analyses as data were not provided.
Prevalent patient data
Biochemical and clinical data for patients with a functioning
transplant followed in either a transplanting or non-transplanting
Table 3.7. Primary renal diagnosis in renal transplant recipients 2009–2014
New transplants by year
Established transplants
on 01/01/2014
2009 2010 2011 2012 2013 2014
Primary renal diagnosis % % % % % % N % N
Aetiology uncertain 14.0 14.1 14.6 12.2 13.0 11.8 347 14.9 4,396
Diabetes 13.1 11.3 13.0 15.2 13.8 15.0 439 10.0 2,943
Glomerulonephritis 23.3 19.8 22.9 23.1 22.8 21.4 628 23.1 6,817
Polycystic kidney disease 13.2 13.5 12.3 13.5 13.8 13.7 402 13.1 3,860
Pyelonephritis 11.2 9.5 10.0 10.4 10.1 8.5 248 13.3 3,906
Reno-vascular disease 6.2 7.0 7.0 7.0 8.3 7.5 219 5.9 1,752
Other 15.9 16.0 17.0 17.0 15.1 17.1 502 17.5 5,145
Not available 3.1 8.8 3.2 1.7 3.2 4.9 145 2.2 648
Table 3.8. Ethnicity of patients who received a transplant in the years 2009–2014
Year % White % S Asian % Black % Other % Unknown
2009 76.2 10.5 6.9 2.1 4.3
2010 76.8 10.6 6.0 2.1 4.4
2011 76.1 9.9 6.5 2.4 5.1
2012 73.3 9.9 7.4 2.9 6.5
2013 71.5 12.0 7.4 2.2 6.9
2014 68.6 12.7 7.3 2.9 8.4
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centre were included in the analyses. The cohort consisted of
prevalent patients as on 31st December 2014. Patients were con-
sidered as having a functioning transplant if ‘transplant’ was listed
as the last mode of RRT in the last quarter of 2014. Patients were
assigned to the renal centre that sent the data to the UKRR but
some patients will have received care in more than one centre. If
data for the same transplant patient were received from both the
transplant centre and non-transplant centre, care was usually
allocated to the non-transplant centre (see appendix B2). Patients
with a functioning transplant of less than three months duration
were excluded from analyses. For haemoglobin, estimated glomer-
ular ﬁltration rate (eGFR), corrected calcium, phosphate and
blood pressure (BP), the latest value in quarter 3 or quarter 4 of
2014 was used.
Estimated glomerular ﬁltration rate (eGFR)
For the purpose of eGFR calculation, the original 4-variable
MDRD formula was used (with a constant of 186) to calculate
Table 3.9a. Percentage completeness of ethnicity, eGFR and blood pressure by centre for prevalent transplant patients on 31/12/2014
Centre N Ethnicitya eGFR
Blood
pressureb
England
B Heart 189 100 93 1
B QEH 1,008 100 94 93
Basldn 78 100 99 82
Bradfd 295 100 94 67
Brightn 407 99 96 0
Bristol 835 100 100 71
Camb 819 98 90 80
Carlis 144 100 95 0
Carsh 627 100 89 0
Chelms 98 99 96 92
Covnt 487 100 96 82
Derby 184 100 96 90
Donc 67 100 97 97
Dorset 320 100 88 74
Dudley 73 100 99 47
Exeter 430 100 98 92
Glouc 173 100 98 92
Hull 389 99 95 1
Ipswi 211 100 97 0
Kent 528 100 98 91
L Barts 995 100 98 0
L Guys 1,200 99 97 0
L Kings 385 100 98 99
L RFree 1,109 99 97 78
L St.G 417 95 97 91
L West 1,699 100 95 0
Leeds 884 100 98 97
Leic 1,077 98 97 39
Liv Ain 12 92 100 0
Liv Roy 861 99 89 1
M RI 1,163 99 96 0
Middlbr 492 100 92 40
Newc 627 100 99 0
Norwch 328 100 98 4
Nottm 598 100 98 84
Oxford 1,057 95 99 17
Plymth 317 100 96 89
Ports 876 99 95 11
Prestn 522 100 99 0
Redng 361 99 99 0
Centre N Ethnicitya eGFR
Blood
pressureb
Salford 436 100 96 0
Sheff 695 100 99 97
Shrew 123 100 89 0
Stevng 263 100 98 25
Sthend 101 100 98 49
Stoke 349 100 99 1
Sund 217 100 98 1
Truro 207 100 100 1
Wirral 14 100 86 0
Wolve 182 100 96 73
York 278 99 95 37
N Ireland
Antrim 93 100 99 97
Belfast 511 100 99 51
Newry 97 100 100 87
Ulster 44 100 100 95
West NI 123 100 100 95
Scotland
Abrdn 268 59 96 n/a
Airdrie 200 62 73 n/a
D & Gall 66 29 94 n/a
Dundee 210 65 99 n/a
Edinb 445 26 97 n/a
Glasgw 989 24 71 n/a
Inverns 139 86 87 n/a
Klmarnk 125 73 61 n/a
Krkcldy 118 38 94 n/a
Wales
Bangor 3 100 100 0
Cardff 995 100 99 98
Clwyd 60 100 88 62
Swanse 308 100 98 98
Wrexm 135 100 99 16
England 25,228 99 96 38
N Ireland 868 100 99 68
Scotland 2,560 41 83 n/a
Wales 1,501 100 99 89
UK 30,157 94 95 42c
aPatients with missing ethnicity were classed as White for eGFR calculation
bScottish centres excluded from blood pressure analysis as data not provided by the Scottish Renal Registry
cExcluding Scotland
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Table 3.9b. Percentage completeness of haemoglobin, serum cholesterol, serum calcium, serum phosphate and serum PTH by
centre for prevalent transplant patients on 31/12/2014
Centre N Haemoglobin
Total serum
cholesterol
Adjusted serum
calciumb
Serum
phosphate
Serum
PTH
England
B Heart 189 92 67 91 90 22
B QEH 1,008 94 92 94 93 77
Basldn 78 99 46 97 87 38
Bradfd 295 93 71 82 57 28
Brightn 407 96 68 93 93 44
Bristol 835 100 95 99 99 99
Camb 819 89 85 90 89 84
Carlis 144 95 63 92 88 14
Carsh 627 89 58 89 89 41
Chelms 98 95 85 96 78 12
Covnt 487 95 1 94 71 46
Derby 184 95 93 95 94 89
Donc 67 97 54 97 97 52
Dorset 320 86 73 86 68 40
Dudley 73 99 92 99 99 75
Exeter 430 98 86 97 97 33
Glouc 173 98 58 97 97 26
Hull 389 95 26 92 92 25
Ipswi 211 95 49 97 97 48
Kent 528 97 80 96 96 19
L Barts 995 98 98 98 98 97
L Guys 1,200 0 61 95 95 43
L Kings 385 98 79 98 98 65
L RFree 1,109 96 76 96 96 83
L St.G 417 97 90 97 97 80
L West 1,699 95 39 95 95 35
Leeds 884 98 98 97 97 36
Leic 1,077 97 95 96 96 48
Liv Ain 12 100 83 100 100 67
Liv Roy 861 89 71 86 86 62
M RI 1,163 96 72 96 96 52
Middlbr 492 91 39 90 90 10
Newc 627 99 92 99 99 65
Norwch 328 97 98 95 95 21
Nottm 598 98 82 96 93 92
Oxford 1,057 98 71 98 98 39
Plymth 317 96 62 93 93 38
Ports 876 95 59 92 90 22
Prestn 522 99 66 98 97 62
Redng 382 99 81 99 87 51
Salford 436 96 89 96 95 56
Sheff 695 99 63 99 99 26
Shrew 123 89 75 82 82 2
Stevng 263 98 60 94 83 47
Sthend 101 98 54 97 94 16
Stoke 349 99 99 99 98 59
Sund 217 97 95 97 97 92
Truro 207 100 99 99 99 92
Wirral 14 86 93 86 86 71
Wolve 182 96 82 95 85 66
York 278 94 59 93 90 13
Outcomes in UK renal transplant
recipients in 2014
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eGFR from the serum creatinine concentration as reported by the
centre (unless otherwise stated). A wide variety of creatinine assays
are in use in clinical biochemistry laboratories in the UK, and it is
not possible to ensure that all measurements of creatinine concen-
tration collected by the UKRR are harmonised. Although many
laboratories are now reporting assay results that have been aligned
to the isotope dilution-mass spectrometry standard (which would
necessitate use of the modiﬁed MDRD formula), this was not the
case at the end of 2014. Patients with valid serum creatinine results
but no ethnicity data were classed as White for the purpose of the
eGFR calculation.
One year post-transplant data
Patients who received a renal transplant between 1st January
2007 and 31st December 2013 were assigned according to the
renal centre in which they were transplanted. In a small number
of instances, the ﬁrst documented evidence of transplantation in
a patient’s record is from a timeline entry in data returned from
a non-transplant centre, in these instances the patient was re-
assigned to the nearest transplant centre.
Patients who had died or experienced graft failure within 12
months of transplantation were excluded from the analyses.
Patients with more than one transplant during 2007–2013 were
included as separate episodes provided each of the transplants
functioned for a year.
For each patient, the most recent laboratory or blood pressure
result for the relevant 4th/5th quarter after renal transplantation
was taken to be representative of the one year post-transplant out-
come. Again, for the purpose of the eGFR calculation patients with
valid serum creatinine results but missing ethnicity data were
classed as White.
Results and conclusions
Post-transplant eGFR in prevalent transplant patients
When interpreting eGFR post-transplantation, it is
important to remember that estimated GFR formulae
only have a modest predictive performance in the trans-
plant population [4]. Median eGFR in each centre and
percentage of patients with eGFR ,30 ml/min/1.73 m2
are shown in ﬁgures 3.2 and 3.3. The median eGFR was
52.5 ml/min/1.73 m2, with 13% of prevalent transplant
recipients having an eGFR ,30 ml/min/1.73 m2.
Table 3.9b. Continued
Centre N Haemoglobin
Total serum
cholesterol
Adjusted serum
calciumb
Serum
phosphate
Serum
PTH
N Ireland
Antrim 93 99 99 94 98 98
Belfast 511 98 99 98 98 29
Newry 97 100 100 99 100 98
Ulster 44 100 100 93 100 48
West NI 123 94 99 96 98 97
Scotland
Abrdn 268 96 n/a 95 94 n/a
Airdrie 200 99 n/a 99 96 n/a
D & Gall 66 98 n/a 95 91 n/a
Dundee 210 99 n/a 98 96 n/a
Edinb 445 97 n/a 95 91 n/a
Glasgw 989 98 n/a 98 97 n/a
Inverns 139 82 n/a 74 68 n/a
Klmarnk 125 98 n/a 99 98 n/a
Krkcldy 118 92 n/a 94 94 n/a
Wales
Bangor 3 100 100 100 100 67
Cardff 995 99 96 99 99 20
Clwyd 60 98 100 95 95 87
Swanse 308 99 90 97 97 70
Wrexm 135 99 99 99 99 98
England 25,228 91 73 95 93 52
N Ireland 868 98 99 97 98 55
Scotlanda 2,560 97 n/a 95 94 n/a
Wales 1,501 99 95 98 98 40
UK 30,157 92 75c 95 94 52c
aDataset provided by the Scottish Renal Registry for Scottish centres shown did not include data on serum cholesterol or serum PTH
bSerum calcium corrected for serum albumin
cExcluding Scotland
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Table 3.10 summarises the proportion of transplant
patients with an eGFR ,30 ml/min/1.73 m2 by centre.
Whilst local repatriation policies on timing of transfer
of care for patients with failing transplants from trans-
plant centres to referring centres might explain some of
the differences, it is notable that both transplanting and
non-transplanting centres feature at both ends of the
scale. The accuracy of the 4–variable MDRD equation
in estimating GFR5 60 ml/min/1.73 m2 is questionable
[5], therefore a ﬁgure describing this is not included in
this chapter.
Figure 3.4 shows the percentage of prevalent patients by
centre with eGFR ,30 ml/min/1.73 m2 as a funnel plot,
enabling a more reliable comparison of outcomes between
centres across the UK. The solid lines show the 2 standard
deviation limits (95%) and the dotted lines the limits for 3
standard deviations (99.9%). With 67 centres included and
a normal distribution, 3–4 centres would be expected to
fall between the 95–99.9% CI (1 in 20) and no centres
should fall outside the 99.9% limits.
There continued to be variation between centres; these
data show over-dispersion with 14 centres falling outside
the 95% CI of which ﬁve centres were outside the 99.9%
CI. Three centres (Nottingham, London St Georges,
London West) fell outside the lower 99.9% CI suggesting
a lower than expected proportion of patients with eGFR
,30 ml/min/1.73 m2. Liverpool Royal and Portsmouth
both fell outside the upper 99.9% CI suggesting a higher
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Fig. 3.2. Median eGFR in prevalent transplant patients by centre on 31/12/2014
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Fig. 3.3. Percentage of prevalent transplant patients by centre on 31/12/2014 with eGFR ,30 ml/min/1.73 m2
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than expected proportion of patients with eGFR,30 ml/
min/1.73 m2.
eGFR in patients one year after transplantation
Graft function at one year post-transplantation may
predict subsequent long term graft outcome [6].
Figures 3.5a, 3.5b, and 3.5c show the median one year
post-transplant eGFR for patients transplanted between
2007–2013, by transplant type. Living kidney donation
had the highest median eGFR at one year (57.4 ml/min/
1.73 m2), followed by donation after brainstem death
(53.6 ml/min/1.73 m2) and donation after circulatory
death (50.1 ml/min/1.73 m2).
Figures 3.6a, 3.6b and 3.6c show one year post-trans-
plant eGFR by donor type and year of transplantation.
An upward trend in eGFR (p = 0.0007) over the time
Table 3.10. Percentage of prevalent transplant patients with eGFR ,30 ml/min/1.73 m2 on 31/12/2014
Centre
Patients with
eGFR data (N)
Percentage with
eGFR ,30 Centre
Patients with
eGFR data (N)
Percentage with
eGFR ,30
Ulster 44 13.6 Stoke 345 9.3
Clwyd 53 15.1 Hull 370 12.4
D & Gall 62 8.1 L Kings 377 10.6
Donc 65 7.7 Redng 380 11.1
Dudley 72 13.9 Brightn 392 12.8
Klmarnk 76 18.4 L St.G 405 8.4
Basldn 77 24.7 Salford 420 15.0
Antrim 92 6.5 Exeter 422 10.7
Chelms 94 17.0 Edinb 432 16.4
Newry 97 7.2 Middlbr 451 9.1
Sthend 99 17.2 Covnt 467 10.3
Shrew 110 8.2 Belfast 505 9.5
Krkcldy 111 17.1 Kent 515 15.3
Inverns 121 13.2 Prestn 517 14.9
West NI 123 8.1 Carsh 561 11.2
Wrexm 134 13.4 Nottm 588 8.8
Carlis 137 10.9 Newc 619 12.8
Airdrie 145 14.5 Sheff 686 11.7
Glouc 170 10.6 Glasgw 703 15.2
Wolve 174 11.5 Camb 733 11.9
B Heart 175 9.7 Liv Roy 764 18.6
Derby 177 9.6 Bristol 831 11.7
Ipswi 205 15.1 Ports 835 20.4
Truro 207 12.1 Leeds 866 14.1
Dundee 208 12.5 B QEH 949 13.2
Sund 212 14.6 L Barts 974 15.5
Abrdn 258 11.6 Cardff 987 12.2
Stevng 259 10.4 Oxford 1,043 12.8
York 264 10.2 Leic 1,048 13.4
Bradfd 276 13.0 L Rfree 1,075 14.4
Dorset 282 10.6 M RI 1,112 15.5
Swanse 303 16.8 L Guys 1,163 13.2
Plymth 304 11.2 L West 1,621 10.2
Norwch 321 14.6
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Fig. 3.4. Funnel plot of percentage of prevalent transplant
patients with eGFR ,30 ml/min/1.73 m2 by centre size on 31/
12/2014
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Fig. 3.5a. Median eGFR one year post-live donor transplant by transplant centre 2007–2013
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Fig. 3.5b. Median eGFR one year post-brainstem death donor transplant by transplant centre 2007–2013
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Fig. 3.5c. Median eGFR one year post-circulatory death donor transplant by transplant centre 2007–2013
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Fig. 3.6a. Median eGFR one year post-live donor transplant by year of transplantation 2007–2013
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Fig. 3.6b. Median eGFR one year post-brainstem death donor transplant by year of transplantation 2007–2013
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Fig. 3.6c. Median eGFR one year post-circulatory death donor transplant by year of transplantation 2007–2013
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period was noticed with live kidney donation trans-
plantation, but not with donation after brainstem
death (p = 0.14) or donation after circulatory death
(p = 0.4).
Haemoglobin in prevalent transplant patients
Transplant patients have previously fallen under the
remit of the UK Renal Association Complications of
Chronic Kidney Disease (CKD) guidelines. Updated
guidelines regarding the management of anaemia in
CKD were published by the association in November
2010 [7] which have now been adopted for this report.
These guidelines recommend ‘achieving a population
distribution centred on a mean of 11 g/dl with a range
of 10–12 g/dl’ [8] (equivalent to 110 g/L, range 100–
120 g/L). However, many transplant patients with good
transplant function will have haemoglobin concentrations
.120 g/L without the use of erythopoiesis stimulating
agents, and so it is inappropriate to audit performance
using the higher limit.
A number of factors including comorbidity, immuno-
suppressive medication, graft function, ACE inhibitor
use, erythropoietin (EPO) use, intravenous or oral iron
use, as well as centre practices and protocols for manage-
ment of anaemia, affect haemoglobin concentrations in
transplant patients. Most of these data are not collected
by the UKRR and therefore caution must be used when
interpreting analyses of haemoglobin attainment.
Figures 3.7a and 3.7b report centre results stratiﬁed
according to graft function as estimated by eGFR. The
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Fig. 3.7a. Median haemoglobin for prevalent transplant patients with eGFR530 ml/min/1.73 m2 by centre on 31/12/2014
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Fig. 3.7b. Median haemoglobin for prevalent transplant patients with eGFR ,30 ml/min/1.73 m2 by centre on 31/12/2014
Outcomes in UK renal transplant
recipients in 2014
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percentage of prevalent transplant patients achieving Hb
5100 g/L in each centre, stratiﬁed by eGFR, is displayed
in ﬁgures 3.8a and 3.8b.
Figure 3.9 describes the percentage of prevalent
patients by centre with haemoglobin ,100 g/L as a
funnel plot enabling more reliable comparison of out-
comes between centres across the UK. With 66 centres
included and a normal distribution, 3–4 centres would
be expected to fall between the 95%–99.9% CI (1 in 20)
and no centres should fall outside the 99.9% CI purely
as a chance event.
One centre (London St Bartholomew’s) fell outside the
upper 99.9% CI and two further centres (Leeds, Glasgow)
fell outside the upper 95% CI indicating a higher than
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Fig. 3.8a. Percentage of prevalent transplant patients with eGFR530 ml/min/1.73 m2 achieving haemoglobin5100 g/L by centre on
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predicted proportion of transplant patients not achieving
the haemoglobin target. Six centres fell outside the lower
99.9% CI, indicating they performed better than expected
with fewer than predicted patients having a haemoglobin
,100 g/L.
Blood pressure in prevalent transplant patients
In the absence of controlled trial data, the opinion
based recommendation of the UK Renal Association
(RA) published in the 2010 guideline for the care of
kidney transplant recipients is that ‘Blood pressure
should be <130/80 mmHg (or <125/75 mmHg if pro-
teinuria)’ [9]. This blood pressure target is the same as
that used in previous annual reports [10].
As indicated in table 3.9a, completeness for blood
pressure data returns was variable and only centres
with.50% data returns were included for consideration.
Despite this restriction, caution needs to be exercised in
interpretation of these results because of the volume of
missing data and potential bias, (e.g. a centre may be
more likely to record and report blood pressure data
electronically in patients with poor BP control).
Figures 3.10a and 3.10b show the percentage of patients
with a blood pressure of ,130/80 mmHg, by eGFR.
The percentage of patients with BP ,130/80 (systolic
BP ,130 and diastolic BP ,80 mmHg) was higher
(26.5% vs. 20.3%) in those with better renal function
(eGFR530 ml/min/1.73 m2).
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Analysis of prevalent patients by CKD stage
Introduction
Approximately 2.4% of prevalent transplant patients
returned to dialysis in 2014, a similar percentage to that
seen over the last few years. Amongst patients with native
chronic kidney disease, late presentation is associated
with poor outcomes, largely attributable to lack of
specialist management of anaemia, acidosis, hyper-
phosphataemia and to inadequate advance preparation
for dialysis. Transplant recipients on the other hand,
are almost always followed up regularly in specialist
transplant or renal clinics and it would be reasonable to
expect patients with failing grafts to receive appropriate
care and therefore have many of their modiﬁable risk
factors addressed before complete graft failure and return
to dialysis.
Methods
The transplant cohort consisted of prevalent transplant recipients
as on 31st December 2014 (N = 28,707) and were classiﬁed accord-
ing to the KDIGO staging criteria with the sufﬁx of ‘T’ to represent
their transplant status. Patients with missing ethnicity information
were classiﬁed as White for the purpose of calculating eGFR. Preva-
lent dialysis patients, except those who commenced dialysis in 2014,
comprised the comparison dialysis cohort (N = 21,408) including
2,222 peritoneal dialysis patients. Only patients on peritoneal dialysis
were considered when examining differences in serum phosphate
between transplant recipients and dialysis patients. For both the
transplant and dialysis cohorts, the analysis used the most recent
available value from the last two quarters of the 2014 laboratory
data. Scottish centres were excluded from blood pressure, cholesterol
and PTH analyses as corresponding data were not provided.
Results and conclusions
Table 3.11 shows that 13% of the prevalent transplant
population (3,732 patients), had moderate to advanced
Table 3.11. Analysis by CKD stage for prevalent transplant patients compared with prevalent dialysis patients on 31/12/2014
Stage 1–2T Stage 3T Stage 4T Stage 5T
(560) (30–59) (15–29) (,15) Stage 5D
Number of patients 10,548 14,427 3,293 439 21,408
% of patients 36.7 50.3 11.5 1.5
eGFR ml/min/1.73 m2 a
mean+ SD 77.6+ 15.6 45.8+ 8.4 23.8+ 4.1 11.9+ 2.4
median 73.5 46.1 24.4 12.3
Systolic BP mmHg
mean+ SD 133.7+ 16.6 136.3+ 17.6 140.2+ 19.4 144.1+ 23.0 133.1+ 25.4
%5130 58.9 64.1 71.9 76.0 53.1
Diastolic BP mmHg
mean+ SD 78.7+ 9.9 78.8+ 10.2 78.7+ 11.4 79.7+ 12.8 68.7+ 14.9
%580 49.4 48.6 49.2 49.2 22.0
Cholesterol mmol/L
mean+ SD 4.4+ 1.0 4.6+ 1.1 4.6+ 1.2 4.6+ 1.3 3.9+ 1.1
%54 66.8 70.6 71.9 65.6 43.4
Haemoglobin g/L
mean+ SD 137.0+ 16.1 128.3+ 16.6 115.7+ 15.3 106.2+ 15.5 111.4+ 13.8
% ,100.0 1.5 3.3 12.1 32.6 17.5
Phosphate mmol/Lb
mean+ SD 0.9+ 0.2 1.0+ 0.2 1.1+ 0.3 1.5+ 0.4 1.6+ 0.4
% .1.7 0.1 0.3 2.6 29.2 35.3
Corrected calcium mmol/L
mean+ SD 2.4+ 0.1 2.4+ 0.1 2.4+ 0.2 2.3+ 0.2 2.4+ 0.2
% .2.5 24.7 24.3 19.6 15.0 16.2
% ,2.2 3.7 4.7 9.3 18.3 16.4
PTH pmol/L
median 8.2 9.5 15.7 31.4 31.5
% .72 0.5 0.6 3.2 15.4 17.2
aPrevalent transplant patients with no ethnicity data were classed as White
bOnly PD patients included in stage 5D, N = 2,222
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renal impairment of eGFR ,30 ml/min/1.73 m2. The
table also demonstrates that patients with failing grafts
achieved UK Renal Association standards for some key
biochemical and clinical outcome variables less often
than dialysis patients. This substantial group of patients
represents a considerable challenge, as resources need
to be channelled to improve key outcome variables and
achieve a safe and timely modality switch to another
form of renal replacement therapy.
eGFR slope analysis
Introduction
The gradient of deterioration in eGFR (slope) may
predict patients likely to have early graft failure. The
eGFR slope and its relationship to speciﬁc patient charac-
teristics are presented here.
Methods
All UK patients aged 5 18 years receiving their ﬁrst renal
transplant between 1st January 2003 and 31st December 2012,
were considered for inclusion. A minimum duration of 18 months
graft function was required and three or more creatinine measure-
ments from the second year of graft function onwards were used to
plot eGFR slope. If a transplant failed but there were at least three
creatinine measurements between one year post-transplant and
graft failure, the patient was included but no creatinine measure-
ments after the quarter preceding the recorded date of transplant
failure were analysed.
Slopes were calculated using linear regression, assuming linear-
ity, and the effect of age, ethnicity, gender, diabetes, donor type,
year of transplant and current transplant status were analysed. P
values were calculated using the Kruskal-Wallis test. eGFR was
calculated using the CKD-EPI equation and results expressed as
ml/min/1.73 m2/year. The CKD-EPI equation was used in prefer-
ence to the MDRD formula as it is thought to have a greater degree
of accuracy at higher levels of eGFR [11].
Results and conclusions
The study cohort consisted of 15,970 patients. The
median GFR slope was −0.48 ml/min/1.73 m2/year
(table 3.12). The gradient was steeper for Black recipients
(−0.94 ml/min/1.73 m2/year), in keeping with previously
published data suggesting poorer outcomes for this group
[12, 13]. There was no statistically signiﬁcant difference
in eGFR slope in recipients of deceased donor kidneys
(−0.51 ml/min/1.73 m2/year) compared to patients who
received organs from live donors (−0.44 ml/min/
1.73 m2/year). Female patients had a steeper slope
(−0.8 ml/min/1.73 m2/year) than males (−0.27 ml/min/
1.73 m2/year), as did diabetic patients (−1.12 ml/min/
1.73 m2/year) compared to non-diabetic patients
(−0.38 ml/min/1.73 m2/year). The slope was steeper in
younger recipients, possibly reﬂecting increased risk of
immunological damage. As might be expected, the
steepest slope was in patients where the transplant sub-
sequently failed. This analysis has assumed linearity of
progression of fall in GFR and further work is ongoing
to characterise the patterns of progression more precisely.
The ﬁndings in this study differ slightly from previous
UKRR work exploring eGFR changes in transplant
recipients [14]. This identiﬁed that male donor to female
recipient transplantation, younger recipients, diabetes,
white ethnicity, and human leukocyte antigen (HLA) mis-
match were associated with faster decline in eGFR. These
differences may be explained by patients with eGFR
.60 ml/min/1.73 m2 at one year post-transplantation
being excluded and the more complex multivariable
model used in the previous work. Udayaraj and colleagues
[14] also adjusted for factors such as HLA mismatch and
donor age, which were not available for the patients
studied in this chapter.
Cause of death in transplant recipients
Introduction
Differences in causes of death between dialysis and
transplant patients may be expected due to selection for
transplantation and use of immunosuppression. Chapter
5 includes a more detailed discussion on cause of death in
dialysis patients.
Methods
The cause of death is sent by renal centres as an ERA-EDTA
registry code. These have been grouped into the following
categories: cardiac disease, cerebrovascular disease, infection,
malignancy, treatment withdrawal, other and uncertain.
Some centres have high data returns to the UKRR regarding
cause of death, whilst others return no information. Provision of
this information is not mandatory. Analysis of prevalent patients
included all those aged over 18 years and receiving RRT on
1st January 2014.
Results and conclusions
Table 3.13 and ﬁgure 3.11 show the differences in the
cause of death between prevalent dialysis and transplant
patients. Table 3.14 shows the cause of death for
prevalent transplant patients by age. Death due to cardio-
vascular disease was less common in transplanted
patients than in dialysis patients, perhaps reﬂecting the
Outcomes in UK renal transplant
recipients in 2014
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cardiovascular screening undertaken during transplant
work-up; transplant recipients are a pre-selected lower
risk group of patients. The leading causes of death
amongst transplant patients were malignancy (26%)
and infection (24%). There has been a reduction over
time in the proportion of deaths in transplant patients
attributed to cardiovascular or stroke disease (43% in
2003 compared to 23% in 2014) with an increase in the
Table 3.13. Cause of death by modality in prevalent RRT patients on 1/1/2014, who died in 2014
All modalities Dialysis Transplant
Cause of death N % N % N %
Cardiac disease 722 23 628 24 94 18
Cerebrovascular disease 136 4 112 4 24 5
Infection 622 20 498 19 124 24
Malignancy 350 11 214 8 136 26
Treatment withdrawal 504 16 490 19 14 3
Other 607 19 517 20 90 17
Uncertain 189 6 154 6 35 7
Total 3,130 2,613 517
No cause of death data 1,564 33 1,313 33 251 33
Table 3.12. Differences in median eGFR slope between subgroups of prevalent transplant patients
Patients characteristics N Median Slope Lower Quartile Upper Quartile p-value
Age at transplant ,40 4,718 −0.95 −3.90 1.09 ,0.0001
40–55 6,117 −0.28 −2.54 1.60
.55 5,135 −0.32 −2.61 1.70
Ethnicity Asian 1,484 −0.82 −3.81 1.57 ,0.0001
Black 1,000 −0.94 −4.06 1.35
Other 347 −0.64 −3.86 1.80
White 12,385 −0.41 −2.76 1.47
Gender Male 9,776 −0.27 −2.59 1.62 ,0.0001
Female 6,194 −0.80 −3.59 1.21
Diabetes Non-diabetic 13,315 −0.38 −2.74 1.54 ,0.0001
Diabetic 2,225 −1.12 −3.96 1.09
Donor Cadaveric 10,340 −0.51 −3.00 1.47 0.2
Live 5,630 −0.44 −2.90 1.51
Year of transplant 2003 973 −0.63 −2.26 0.72 ,0.0001
2004 1,141 −0.37 −2.03 0.85
2005 1,134 −0.31 −2.01 1.06
2006 1,442 −0.61 −2.57 0.95
2007 1,579 −0.64 −2.51 1.00
2008 1,810 −0.50 −2.61 1.14
2009 1,891 −0.72 −3.18 1.13
2010 1,978 −0.44 −3.25 1.83
2011 1,926 −0.08 −3.82 2.86
2012 2,096 −0.04 −5.29 5.05
Status of transplant Died 1,115 −0.69 −3.90 1.93 ,0.0001
at end of follow-up Failed 1,164 −6.24 −12.02 −2.95
Re-transplanted 56 −4.31 −7.47 −1.94
Functioning 13,635 −0.22 −2.28 1.64
All 15,970 −0.48 −2.97 1.49
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proportion ascribed to infection or malignancy (30% in
2003 compared to 50% in 2014). This change has also
been reported in other registries, e.g. ANZDATA
(http://www.anzdata.org.au) and may reﬂect better
management of cardiovascular risk (although table 3.11
shows blood pressure management remained sub-
optimal). Explanations for the rising death rate secondary
to malignancy may include the increasing age of
transplant recipients and the increased intensity of
immunosuppressive regimens leading to complications
of over-immunosuppression.
Conﬂicts of interest: Dr I MacPhee has received research
funding and speaker honoraria from Astellas and speaker honor-
aria from Chiesi.
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Appendix 1: Reporting status of audit measures
Table 3.15. The reporting status of the recommended Renal Association Audit Measures for the Post-operative Care of Kidney
Transplant Recipients in the 18th Annual Report
RA audit measure
Included in
UKRR annual
report? Reason for non-inclusion
1. Proportion of blood results available for review, and reviewed,
within 24 hours
No UKRR does not currently collect these data
2. Proportion of units with a written follow-up schedule available to
all staff and patients
No UKRR does not currently collect these data
3. Percentage of patients accessing their results through Renal
Patient View
No Requires linkage with RPV
4. Percentage of total patients assessed in an annual review clinic. No UKRR does not currently collect these data
5. Percentage of total patients receiving induction with ILRAs and
TDAs
No Poor data completeness
6. Percentage of de novo KTRs receiving tacrolimus No Poor data completeness
7. Percentage of de novo KTRs receiving MPA based
immunosuppression
No Poor data completeness
8. Percentage of de novo KTRs receiving corticosteroid maintenance
therapy
No Poor data completeness
9. Use of generic agents No UKRR does not currently collect these data
10 Severity of biopsy proven acute rejection (BPAR) recorded by
BANFF criteria.
No UKRR does not currently collect these data
11. Percentage of KTRs with BPAR in ﬁrst 3 months and ﬁrst 12
months.
No UKRR does not currently collect these data
12. Percentage of KTRs requiring TDAs to treat rejection in ﬁrst year No UKRR does not currently collect these data
13. Complication rates after renal transplant biopsy No UKRR does not currently collect these data
14. Proportion of patients receiving a target blood pressure of 130/
80 mmHg or 125/75 mmHg in the presence of proteinuria
(PCR.100 or ACR,70)
No Poor data completeness
15. Proportion of patients receiving an ACE inhibitor or angiotensin
receptor blocker
No Poor data completeness
16. Proportion of patients with proteinuria assessed by dipstick and,
if present, quantiﬁed at each clinic visit.
No UKRR does not currently collect these data
17. Proportion of renal transplant recipients with an annual fasting
lipid proﬁle
No UKRR does not currently collect these data
18. Proportion of KTR taking statins (including the type of statin)
for primary and secondary prevention of premature
cardiovascular disease
No UKRR does not currently collect these data
19. Proportion of patients on other lipid lowering agents No Poor data completeness
20. Proportion of patients achieving dyslipidaemia targets Yes
21. Incidence of new onset diabetes after transplantation (NODAT)
at three months and at annual intervals thereafter
No UKRR does not currently collect these data
22. Proportion of patients who require insulin, and in whom
remedial action is undertaken – minimisation of steroids and
switching of CNIs
No UKRR does not currently collect these data
23. Proportion of patients with ischaemic heart disease No Poor data completeness
24. Proportion of patients suffering myocardial infarction No Poor data completeness
25. Proportion of patients undergoing primary revascularisation No Poor data completeness
26. Proportion of patients receiving secondary prevention with a
statin, anti-platelet agents and RAS blockers
No UKRR does not currently collect these data
Outcomes in UK renal transplant
recipients in 2014
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Table 3.15. Continued
RA audit measure
Included in
UKRR annual
report? Reason for non-inclusion
27. Proportion of patients who are obese No Poor data completeness
28. Proportion of patients having screening procedures for neoplasia
at the annual review clinic
No UKRR does not currently collect these data
29. Incidence of CMV disease No Poor data completeness
30. Rate of EBV infection and PTLD No UKRR does not currently collect these data
31. Completeness of records for EBV donor and recipient serology No UKRR does not currently collect these data
32. Rates of primary VZV and shingles infection No UKRR does not currently collect these data
33. Completeness of records for VZV recipient serology No UKRR does not currently collect these data
34. Rates and outcomes of HSV infection. No UKRR does not currently collect these data
35. Rates of BK viral infection in screening tests. No UKRR does not currently collect these data
36. Rates and outcomes of BK nephropathy No UKRR does not currently collect these data
37. Frequency of bisphosponate use No UKRR does not currently collect these data
38. Incidence of fractures No UKRR does not currently collect these data
39. Incidence of hyperparathyroidism No Poor data completeness
40. Incidence of parathyroidectomy No UKRR does not currently collect these data
41. Use of cinacalcet No Poor data completeness
42. Frequency of hyperuricaemia and gout No UKRR does not currently collect these data
43. Prevalence of anaemia Yes
44. Prevalence of polycythaemia No Poor data completeness
45. Pregnancy rates and outcomes No UKRR does not currently collect these data
46. Prevalence of sexual dysfunction No UKRR does not currently collect these data
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